From: Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
Ligand ID
Ethyl ester
Methyl ester
Active site
Binding site
Zinc0252
–
Cys482
Zinc3190
Zinc2764
His615
Asn622
Zinc5651
Zinc8789
Glu480